Lionel Bouchet

Role: Senior Vice President, Commercial Development at Mevion Medical Systems
Location: Natick, MA, US
LinkedIn followers: 500 followers

Sales & Business DevelopmentView LinkedIn profile

Experience

Senior Vice President, Commercial Development
Mevion Medical Systems
Jan 2022 — Present
Lead commercialization team • Lead marketing team

Skills

Mri
Cancer
Business Development
Product Marketing
Software Development
Medical Physics
Product Lifecycle Management
R&D
Digital Imaging
Hardware Diagnostics
Product Development
Radiation Therapy
Strategic Partnerships
Strategic Planning
Radiology
Pacs
Molecular Imaging
X-Ray
Product Management
Medical Imaging
Building Relationships
Oncology
Medical Devices
Market Analysis
Market Development
Cross-Functional Team Leadership
Dosimetry
Nuclear Medicine
Research and Development (R&D)
Dicom
Capital Equipment
Product Strategy
Product Launch
Healthcare
Biomedical Engineering
Radiation

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@mevion.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Mevion Medical Systems

Medical Equipment Manufacturing · 251 employees · Founded 2004 · Littleton, Massachusetts, United States

Mevion Medical Systems, Inc. is a leading provider of proton therapy systems for use in radiation treatment for cancer patients. Mevion is privately held and based in Littleton, Massachusetts, with international offices in the United Kingdom and Japan and a joint venture in China. For more information, please visit www.mevion.com. About the MEVION S250 Series: The MEVION S250 Series is elegantly designed to deliver high-powered, efficient proton therapy treatments. Built upon the world’s only gantry-mounted proton accelerator and benefitting from Mevion’s patented direct beam technology, the MEVION S250 Series delivers on the therapeutic promise of proton therapy while enhancing beam quality, stability and uptime. The result is reduced system complexity, higher reliability and throughput, and lower capital and operating costs—making the MEVION S250 Series a compelling, financially viable solution for all cancer centers. The Series is comprised of: • MEVION S250, offering highly stable, next-generation volumetric delivery capabilities • MEVION S250i with HYPERSCAN technology, overcoming pencil beam scanning uncertainties by delivering robust Intensity Modulated Proton Therapy treatment at hyper-speed • MEVION S250mx, making proton therapy fully scalable, with two, three and four room designs that are inherently redundant and guarantee 100 percent facility uptime

mevion.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Senior Vice President, Commercial Development

Skills

Find verified contacts for anyone on LinkedIn